
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and... Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1 | -8 | 1.25 | 1.25 | 1.13 | 28447 | 1.18666121 | CS |
4 | -0.15 | -11.5384615385 | 1.3 | 1.3785 | 1.08 | 40925 | 1.19527218 | CS |
12 | -0.24 | -17.2661870504 | 1.39 | 1.7 | 1.08 | 39452 | 1.2763065 | CS |
26 | -0.68 | -37.1584699454 | 1.83 | 2.52 | 1.08 | 101323 | 1.60668428 | CS |
52 | -12.05 | -91.2878787879 | 13.2 | 13.6496 | 1.08 | 414219 | 2.83245911 | CS |
156 | -572.962 | -99.7996906527 | 574.112 | 788.48 | 1.08 | 1244312 | 246.04942846 | CS |
260 | -9583.81 | -99.9880020365 | 9584.96 | 19440.96 | 1.08 | 2167483 | 2259.9008687 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions